Conformal Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer That Has Spread to the Liver
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The researchers are doing this study to test the combination of conformal radiation therapy
(RT) and standard chemotherapy in people with metastatic pancreatic cancer that has spread to
the liver. The researchers will try to find the highest safe and effective dose of conformal
RT that can be given to the liver when combined with standard chemotherapy. The conformal RT
treatment plan will include higher doses of radiation to the areas of the liver where tumors
can be seen, and a lower dose to the entire liver. The study will also look at blood samples
from participants to learn why some people may respond to study treatment (conformal RT in
combination with standard chemotherapy) better than others.